You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 442-C A best-in-class HSC-derived CAR-Monocyte product with a novel CAR costimulatory domain significantly improves CAR-M activity against solid tumors

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Cellular Therapies
442-C A best-in-class HSC-derived CAR-Monocyte product with a novel CAR costimulatory domain significantly improves CAR-M activity against solid tumors

 

Online download statistics by month:

Online download statistics by month: October 2023 to June 2025

AbstractFullPdf
Oct 2023200
Nov 2023196010
Dec 20237304
Jan 20246201
Feb 20246008
Mar 20245009
Apr 20245406
May 202486010
Jun 20243204
Jul 20244402
Aug 20242805
Sep 20242801
Oct 202486011
Nov 20245402
Dec 20244808
Jan 20255005
Feb 20251403
Mar 20250017
Apr 20250016
May 2025003
Jun 2025004
Total9670129